Shandong Boan Biotechnology Co., Ltd. (HKG:6955)

HKG:6955 Revenue

Shandong Boan Biotechnology had revenue of 233.00M CNY in the half year ending June 30, 2026, a decrease of -35.80%. This brings the company's total for the last twelve months to 624.41M, down -17.49% year-over-year. In the year 2025, Shandong Boan Biotechnology had annual revenue of 784.82M with 8.06% growth. That makes Shandong Boan Biotechnology the 23,317th largest company in the world by revenue and 1,384th in Hong Kong.

• Revenue (ttm): 624.41M CNY
• Revenue Growth: -17.49%
• P/S Ratio: 2.70
• Revenue / Employee: 904.94K CNY
• Employees: 690
• Market Cap: 1.87B HKD

Revenue Chart

Chart

Chart

* This company reports financials in CNY.

Revenue by Geography

Chart

• Mainland China 747.63M 95.3%
• Other Countries 37.19M 4.7%

Fiscal year ended Dec 31, 2025 See the full HKG:6955 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	784.82M	58.51M	8.06%
Dec 31, 2024	726.32M	108.19M	17.50%
Dec 31, 2023	618.13M	102.17M	19.80%
Dec 31, 2022	515.96M	357.26M	225.11%
Dec 31, 2021	158.70M	-	-

Data Source: S&P Global Market Intelligence Last updated: Sep 29, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Nov 2, 2026

Data Sources Report a data error